



Chappell et al. (1) propose several valid
ideas and procedures for accomplishing
better drinking water standards for arsenic,
a metalloid long known to be carcinogenic
to humans (2-4). Another necessary rec-
ommendation, and in our opinion an
obvious need, apparently not stated specifi-
cally in the Chappell et al. review on
arsenic (1) is that we should test arsenic for
long-term toxicity- and carcinogenicity in
laboratory animals. In our view, adequate
long-term carcinogenesis bioassays have
not been done on this metal or its com-
mon environmental and commercial inor-
ganic derivatives. However, some evidence
of carcinogenicity in animals has been
reported but has not been associated
specifically with arsenic, mainly because
these experimental studies have been con-
sidered inadequate due to other confound-
ing agents; for example, inappropriate or
absent controls, and in one study arsenic
was given with copper sulfate (Bordeaux
mixture) to mimic the actual antifungal
agent used in vineyards (4,5).
Arsenite undergoes methylation in liver
nonenzymatically to methanearsonic acid
and enzymatically to monomethylarsonic
acid (MMA), andsubsequently to dimethy-
larsinic acid (DMA) via oxidative addition
ofa methyl groupwith S~adenosylmethion-
ine as the methyl donor. Enzymatic methy-
lation is thought to detoxify arsenic. One
reason given for the apparent lack of car-
cinogenicity of arsenic in animals is the
methylation differential between humans
and rodents. Humans excrete more MMA
and less DMA, indicating effective methy-
lation, than most rodent species (mice, rab-
bits, and hamsters), except rats, which dis-
play a unique biokinetics because they
sequester arsenic in hemoglobin in red
blood cells. This implied lower capacity to
detoxify arsenic via methylation may be
related to nutrition, particularly with nutri-
ents associated with production of methyl
donor groups. Nutrition appears to play an
influential role in sensitivity to arsenic car-
cinogenesis. Poor nutrition may be the
underlying reasonwhycarcinogenic activity
of arsenic is often seen in lower socioeco-
nomic individuals. In arsenic carcinogenesis
studies, we recommend the use of a diet
with marginally low methyl content rather
than the high protein laboratory chows cur-
rently used or available on the market.
Prior carcinogenicity studies using rodents
have consistently ignored this important
aspect ofarsenic metabolism.
Also in our view, we would suggest
long-term inhalation studies using arsenic
trioxide, the most common arsenic com-
pound considered carcinogenic to humans.
This could be done in both sexes of mice
(using a strain known to methylate
arsenic), and perhaps in rats as well.
Further, another study could be done
using drinking water as the medium for
administering arsenic; as suggested by
Chappell et al. (1), exposure levels could
be geared toward actual and multiples of
drinking water levels in the environment.
Ofcourse the highest exposure levels must
be those typically chosen for long-term
carcinogenicity studies (6,7). In addition,
these studies should be conducted for
longer periods of time than the standard
104 weeks to allow the opportunity for any
late-stage carcinogenic effects to be mani-
fested; perhaps 30 months or longer would
be more adequate. Additionally, some
experimental efforts could be directed to
initiator-promoter systems.
In another testing scenario that is more
environmentally based, the same animals
could be exposed to arsenic via various
media simultaneously to more closely
model actual conditions for humans
exposed to arsenic; that is, expose groups of
animals with arsenic in drinking water, in
food, and by inhalation-just like humans
are exposed. One should additionally use
groups exposed simultaneously to chlori-
nated drinking water (a suspected human
carcinogen for the urinary bladder), rather
than the typically deionized or distilled
water used in long-term drinking water
experiments. These proposed long-term
studies could serve at least two purposes: 1)
to generate more appropriate data to allow
better environmental risk assessments to be
made, especially for drinking water stan-
dards (1); and 2) to best answer the long-
held view that arsenic may be a paradoxical
carcinogen; that is, carcinogenic to humans
but not to laboratory animals. In our opin-
ion, given that arsenic has not been studied
adequately and that some earlier experi-
ments have shown limited evidence ofcar-
cinogenicactivity, the useofcurrent experi-
mental design conditions will show arsenic
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Environmental Lead Is a
Problem in Lima, Peru
Blood lead levels as low as 10 pg/dl pose a
threat to children's development (1). In
Latin America's major cities, still afflicted
by the massive use of leaded gasoline,
prevalences above that level range from 25
to 100%.
Hitherto, no information exists on the
magnitude ofhigh blood levels in Peru. In
the capital city ofLima, nowwith 8 million
inhabitants, the most contaminated districts
are those located in the northeastern sector,
where most ofthe city's lead emissions are
mobilized by a typical wind pattern. In
1991, the amount oflead partides that set-
tled on the ground in the district of San
Juan de Lurigancho was 0.015 metric tons
per square kilometer in 30 days, three times
higher than the upper tolerable limit (2). In
1993, the Peruvian Ministry of Health (3)
reported that Lima's monthly average con-
centration oflead in the air (in micrograms
per cubic meter) was 2.6 in April; 2.05 in
May; 2.18 inJune; and 1.5 on average from
July through December. All exceeded the
annual maximum limitof0.5plg/m3.
For preschool children, the lead health
hazard is compounded by iron deficiency
anemia, which is highly prevalent in this
age group. In fact, several studies indicate
that low iron stores may result in greater
susceptibility to lead absorption by
humans (4).
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